• Length:
    7 Weeks
  • Effort:
    5–7 hours per week
  • Price:

    FREE
    Add a Verified Certificate for $149 USD

  • Institution
  • Subject:
  • Level:
    Intermediate
  • Language:
    English
  • Video Transcript:
    English
  • Course Type:
    Instructor-led on a course schedule

Prerequisites

Cell Biology

About this course

Skip About this course

The success of CAR-T cell therapies, driven by their unprecedented efficacy and recent regulatory approvals, has kick-started a new wave of interest into cells as therapies. Yet manufacturing is the link between an exciting new development in the laboratory and a commercial therapy available to the patients who need it. This course will introduce learners to this new field through the following topics.

  • Cellular therapies are living products that are only effective when delivered alive. This course will introduce the basic cellular biology that controls cellular growth and metabolism.
  • The enhanced function of some cell therapies relies on our ability to genetically engineer the cells. This course will teach the current and emerging approaches that are used for genetic modification.
  • This course will teach how we isolate cells from patients or donors and then manipulate them, including helping those cells to grow and multiply outside of the body, to produce a living product at a therapeutically relevant dose.
  • We also need to have confidence that the product we have made is safe and effective and that the process we have used to make it did not encounter any unanticipated obstacles along the way. This course will teach some of the analytical methods used to do this and why these methods were chosen.
  • As these are often individualized therapies, how do you reproducibly manufacture a highly complex living therapy for all of the patients who may need it? This course will teach about the unique characteristics of cell therapies and how those characteristics drive manufacturing, delivery, and supply chain decisions.
  • Cell therapies are part of the larger pharmaceutical industry, which operates under regulatory oversight. This course will teach about how drugs are regulated and how those regulations are applied specifically to cellular therapies.

This course is intended to provide an overview of the key concepts needed to manufacture a cell therapy for learners interested in entering this exciting new field.

What you'll learn

Skip What you'll learn
  • cell biology and immunology
  • cell therapy manufacturing practices
  • analytics for cell therapy
  • industrialization of cell therapies
  • regulatory requirements for cell therapies

Meet your instructors

Krystyn Van Vliet
Professor
Massachusetts Institute of Technology
Paul W. Barone
Co-Director of Biomanufacturing@MIT-CBI
Massachusetts Institute of Technology
Caleb Neufeld
Research Scientist
Massachusetts Institute of Technology
Stacy L. Springs
Senior Director of Programs; Executive Director, Biomanufacturing Initiatives
Massachusetts Institute of Technology

Pursue a Verified Certificate to highlight the knowledge and skills you gain
$149 USD

View a PDF of a sample edX certificate
  • Official and Verified

    Receive an instructor-signed certificate with the institution's logo to verify your achievement and increase your job prospects

  • Easily Shareable

    Add the certificate to your CV or resume, or post it directly on LinkedIn

  • Proven Motivator

    Give yourself an additional incentive to complete the course

  • Support our Mission

    edX, a non-profit, relies on verified certificates to help fund free education for everyone globally

Who can take this course?

Unfortunately, learners from one or more of the following countries or regions will not be able to register for this course: Iran, Cuba and the Crimea region of Ukraine. While edX has sought licenses from the U.S. Office of Foreign Assets Control (OFAC) to offer our courses to learners in these countries and regions, the licenses we have received are not broad enough to allow us to offer this course in all locations. edX truly regrets that U.S. sanctions prevent us from offering all of our courses to everyone, no matter where they live.